These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22766282)

  • 1. Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides.
    Bandyopadhyay S; Katare OP; Singh B
    Colloids Surf B Biointerfaces; 2012 Dec; 100():50-61. PubMed ID: 22766282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.
    Singh G; Pai RS
    Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol.
    Singh B; Singh R; Bandyopadhyay S; Kapil R; Garg B
    Colloids Surf B Biointerfaces; 2013 Jan; 101():465-74. PubMed ID: 23010056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters.
    Bandyopadhyay S; Katare OP; Singh B
    Expert Opin Drug Deliv; 2014 Apr; 11(4):479-92. PubMed ID: 24386966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment.
    Bali V; Ali M; Ali J
    Int J Pharm; 2011 Jan; 403(1-2):46-56. PubMed ID: 20969935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic development of optimized SNEDDS of artemether with improved biopharmaceutical and antimalarial potential.
    Tripathi CB; Beg S; Kaur R; Shukla G; Bandopadhyay S; Singh B
    Drug Deliv; 2016 Nov; 23(9):3209-3223. PubMed ID: 27022886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential.
    Beg S; Jena SS; Patra ChN; Rizwan M; Swain S; Sruti J; Rao ME; Singh B
    Colloids Surf B Biointerfaces; 2013 Jan; 101():414-23. PubMed ID: 23010049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QbD-Oriented Development of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) of Valsartan with Improved Biopharmaceutical Performance.
    Bandyopadhyay S; Beg S; Katare OP; Sharma G; Singh B
    Curr Drug Deliv; 2015; 12(5):544-63. PubMed ID: 25731868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization.
    Singh G; Pai RS
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1023-32. PubMed ID: 24820316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation.
    Dixit RP; Nagarsenker MS
    Eur J Pharm Sci; 2008 Oct; 35(3):183-92. PubMed ID: 18652892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, optimization, and characterization of solid self-nanoemulsifying drug delivery systems of valsartan using porous carriers.
    Beg S; Swain S; Singh HP; Patra ChN; Rao ME
    AAPS PharmSciTech; 2012 Dec; 13(4):1416-27. PubMed ID: 23070560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design.
    Shahnaz G; Hartl M; Barthelmes J; Leithner K; Sarti F; Hintzen F; Rahmat D; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):171-80. PubMed ID: 21303694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
    Bali V; Ali M; Ali J
    J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of cosurfactant effect on nanoemulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system.
    Parmar N; Singla N; Amin S; Kohli K
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):327-38. PubMed ID: 21550214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.
    Balakumar K; Raghavan CV; selvan NT; prasad RH; Abdu S
    Colloids Surf B Biointerfaces; 2013 Dec; 112():337-43. PubMed ID: 24012665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol.
    Singh G; Pai RS
    Artif Cells Nanomed Biotechnol; 2016; 44(2):510-6. PubMed ID: 25331709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance.
    Beg S; Sandhu PS; Batra RS; Khurana RK; Singh B
    Drug Deliv; 2015; 22(6):765-84. PubMed ID: 24673611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.